Matty Vrolix

2.0k total citations
39 papers, 1.5k citations indexed

About

Matty Vrolix is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matty Vrolix has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matty Vrolix's work include Coronary Interventions and Diagnostics (18 papers), Cardiac Imaging and Diagnostics (17 papers) and Acute Myocardial Infarction Research (9 papers). Matty Vrolix is often cited by papers focused on Coronary Interventions and Diagnostics (18 papers), Cardiac Imaging and Diagnostics (17 papers) and Acute Myocardial Infarction Research (9 papers). Matty Vrolix collaborates with scholars based in Belgium, France and Netherlands. Matty Vrolix's co-authors include Jan Piessens, Hilaire De Geest, Frank Wuytack, R. Casteels, Luc Raeymaekers, Walter Desmet, J L Willems, Johan Vanhaecke, Michel E. Bertrand and Victor Legrand and has published in prestigious journals such as Circulation, Circulation Research and Biochemical Journal.

In The Last Decade

Matty Vrolix

37 papers receiving 1.4k citations

Peers

Matty Vrolix
M. Hamon France
Matty Vrolix
Citations per year, relative to Matty Vrolix Matty Vrolix (= 1×) peers M. Hamon

Countries citing papers authored by Matty Vrolix

Since Specialization
Citations

This map shows the geographic impact of Matty Vrolix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matty Vrolix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matty Vrolix more than expected).

Fields of papers citing papers by Matty Vrolix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matty Vrolix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matty Vrolix. The network helps show where Matty Vrolix may publish in the future.

Co-authorship network of co-authors of Matty Vrolix

This figure shows the co-authorship network connecting the top 25 collaborators of Matty Vrolix. A scholar is included among the top collaborators of Matty Vrolix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matty Vrolix. Matty Vrolix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lüscher, Thomas F., Michał Tendera, Matty Vrolix, et al.. (2009). A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. European Heart Journal. 30(13). 1590–1597. 70 indexed citations
2.
Doucet, Serge, David Hilton, Matty Vrolix, et al.. (2000). The SISA study: A randomized comparison of balloon angioplasty and stent to prevent restenosis in small arteries: 6 Month angiographic and 12 month clinical outcome. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 102(18). 663–663. 4 indexed citations
3.
Vrolix, Matty, Victor Legrand, Johan H. C. Reiber, et al.. (2000). Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial). The American Journal of Cardiology. 86(4). 385–389. 77 indexed citations
4.
Suryapranata, Harry, Jean Boland, Michael Pieper, et al.. (2000). Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trial. PubMed. 3(1). 21–28. 7 indexed citations
5.
Vrolix, Matty & Jan Piessens. (1994). Usefulness of the Wiktor Stent for treatment of threatened or acute closure complicating coronary angioplasty. The American Journal of Cardiology. 73(11). 737–741. 25 indexed citations
6.
Vrolix, Matty, et al.. (1994). Bail‐Out Stenting With Medtronic Wiktor™: Results from the European Stent Study Group. Journal of Interventional Cardiology. 7(6). 549–555. 1 indexed citations
7.
Piessens, Jan, Francis Stammen, Matty Vrolix, et al.. (1993). Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Catheterization and Cardiovascular Diagnosis. 28(2). 99–105. 54 indexed citations
8.
Desmet, Walter, et al.. (1993). Intra- and interobserver variability of a fast on-line quantitative coronary angiographic system. International journal of cardiac imaging. 9(4). 249–256. 14 indexed citations
9.
Stammen, Francis, James J. Glazier, Matty Vrolix, et al.. (1992). Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris. The American Journal of Cardiology. 69(19). 1533–1537. 24 indexed citations
10.
Stammen, Francis, Jan Piessens, James J. Glazier, et al.. (1992). The conservative coronary angioplasty strategy after thrombolysis for acute myocardial infarction: immediate and short-term results. American Heart Journal. 124(5). 1127–1132. 1 indexed citations
12.
Desmet, Walter, Johan Vanhaecke, Matty Vrolix, et al.. (1992). Isolated single coronary artery: a review of 50 000 consecutive coronary angiographies. European Heart Journal. 13(12). 1637–1640. 189 indexed citations
13.
Glazier, James J., et al.. (1992). The Role Of Percutaneous Transvenous Balloon Mitral Valvuloplasty In The Treatment Of Patients With Symptomatic Mitral Stenosis. Acta Clinica Belgica. 47(4). 256–263. 1 indexed citations
14.
Vrolix, Matty, et al.. (1991). Lack of evidence for small vessel disease in a patient with „slow dye progression” in the coronary arteries. Catheterization and Cardiovascular Diagnosis. 23(2). 117–120. 24 indexed citations
15.
Piessens, Jan, et al.. (1991). Long-term prognosis of male patients with an isolated chronic occlusion of the left anterior descending coronary artery. American Heart Journal. 122(6). 1542–1547. 10 indexed citations
16.
Timmermans, Carl, Matty Vrolix, Johan Vanhaecke, et al.. (1991). Ridogrel in the setting of percutaneous transluminal coronary angioplasty. The American Journal of Cardiology. 68(5). 463–466. 13 indexed citations
17.
Vrolix, Matty, et al.. (1991). Coronary hemodynamics and coronary flow reserve after intracoronary diltiazem in humans. The American Journal of Cardiology. 68(17). 1633–1637. 5 indexed citations
18.
Vrolix, Matty, Jan Piessens, P. Moerman, Johan Vanhaecke, & Hilaire De Geest. (1989). Fatal aortic rupture: An unusual complication of percutaneous balloon valvuloplasty for acquired valvular aortic stenosis. Catheterization and Cardiovascular Diagnosis. 16(2). 119–122. 4 indexed citations
19.
Piessens, Jan, Tomasz Brzostek, Francis Stammen, et al.. (1989). Effect of intravenous diltiazem on myocardial ischemia occurring during percutaneous transluminal coronary angioplasty. The American Journal of Cardiology. 64(18). 1103–1107. 11 indexed citations
20.
Vrolix, Matty, Johan Vanhaecke, Jan Piessens, & Hilaire De Geest. (1988). An unusual case of guide wire fracture during percutaneous transluminal coronary angioplasty. Catheterization and Cardiovascular Diagnosis. 15(2). 99–102. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026